Ricart E - Search Results

1

Comparison of Diagnostic Accuracy and Impact of Magnetic Resonance Imaging and Colonoscopy for the Management of Crohn's Disease.

García-Bosch O, Ordás I, Aceituno M, Rodríguez S, Ramírez AM, Gallego M, Ricart E, Rimola J, Panes J. García-Bosch O, et al. Among authors: ricart e. J Crohns Colitis. 2016 Jun;10(6):663-9. doi: 10.1093/ecco-jcc/jjw015. Epub 2016 Jan 18. J Crohns Colitis. 2016. PMID: 26783346

2

Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: a pilot, prospective, multicenter, randomized study.

Ricart E, Esteve M, Andreu M, Casellas F, Monfort D, Sans M, Oudovenko N, Lafuente R, Panes J. Ricart E, et al. World J Gastroenterol. 2007 Apr 21;13(15):2193-7. doi: 10.3748/wjg.v13.i15.2193. World J Gastroenterol. 2007. PMID: 17465500 Free PMC article. Clinical Trial.

3

Are we giving biologics too late? The case for early versus late use.

Ricart E, García-Bosch O, Ordás I, Panés J. Ricart E, et al. World J Gastroenterol. 2008 Sep 28;14(36):5523-7. doi: 10.3748/wjg.14.5523. World J Gastroenterol. 2008. PMID: 18810770 Free PMC article. Review.

4

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.

Rimola J, Rodriguez S, García-Bosch O, Ordás I, Ayala E, Aceituno M, Pellisé M, Ayuso C, Ricart E, Donoso L, Panés J. Rimola J, et al. Among authors: ricart e. Gut. 2009 Aug;58(8):1113-20. doi: 10.1136/gut.2008.167957. Epub 2009 Jan 9. Gut. 2009. PMID: 19136510 Free article.

5

Risk factors and characteristics of extent progression in ulcerative colitis.

Etchevers MJ, Aceituno M, García-Bosch O, Ordás I, Sans M, Ricart E, Panés J. Etchevers MJ, et al. Among authors: ricart e. Inflamm Bowel Dis. 2009 Sep;15(9):1320-5. doi: 10.1002/ibd.20897. Inflamm Bowel Dis. 2009. PMID: 19235909

6

Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease.

Rimola J, Rodríguez S, García-Bosch O, Ricart E, Pagès M, Pellisé M, Ayuso C, Panés J. Rimola J, et al. Among authors: ricart e. Radiographics. 2009 May-Jun;29(3):701-19. doi: 10.1148/rg.293085115. Radiographics. 2009. PMID: 19448111 Review.

7

MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.

Cantó E, Moga E, Ricart E, Garcia-Bosch O, Garcia-Planella E, Juarez C, Vidal S. Cantó E, et al. Among authors: ricart e. Inflamm Bowel Dis. 2009 Nov;15(11):1686-96. doi: 10.1002/ibd.21013. Inflamm Bowel Dis. 2009. PMID: 19572373

8

Cell therapies for inflammatory bowel diseases.

Salas A, Ricart E, Panés J. Salas A, et al. Among authors: ricart e. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):321-4. doi: 10.1586/egh.09.26. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19673617 Free article. No abstract available.

9

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A. Veny M, et al. Among authors: ricart e. Aliment Pharmacol Ther. 2010 Mar;31(5):561-72. doi: 10.1111/j.1365-2036.2009.04209.x. Epub 2009 Dec 3. Aliment Pharmacol Ther. 2010. PMID: 19958311 Free article.

10

Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approach.

Etchevers MJ, Ordás I, Ricart E. Etchevers MJ, et al. Among authors: ricart e. Drugs. 2010;70(2):109-20. doi: 10.2165/11533700-000000000-00000. Drugs. 2010. PMID: 20108987 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters